UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1863) 1863
science & technology (1592) 1592
life sciences & biomedicine (1486) 1486
fusion proteins, bcr-abl - antagonists & inhibitors (1002) 1002
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (921) 921
imatinib mesylate (920) 920
oncology (787) 787
benzamides (780) 780
fusion proteins, bcr-abl - genetics (770) 770
hematology (699) 699
protein-tyrosine kinases - antagonists & inhibitors (671) 671
fusion proteins, bcr-abl - metabolism (596) 596
animals (584) 584
leukemia, myelogenous, chronic, bcr-abl positive - genetics (563) 563
pyrimidines - pharmacology (555) 555
pyrimidines - therapeutic use (521) 521
biological and medical sciences (504) 504
protein kinase inhibitors - therapeutic use (497) 497
chronic myeloid leukemia (493) 493
antineoplastic agents - therapeutic use (481) 481
medical sciences (471) 471
piperazines - pharmacology (460) 460
protein kinase inhibitors - pharmacology (460) 460
piperazines - therapeutic use (451) 451
antineoplastic agents - pharmacology (430) 430
leukemia, myelogenous, chronic, bcr-abl positive - pathology (429) 429
leukemia (423) 423
mice (399) 399
hemic and lymphatic diseases (398) 398
female (348) 348
mutation (336) 336
male (333) 333
cell line, tumor (317) 317
apoptosis - drug effects (310) 310
drug resistance, neoplasm (302) 302
hematologic and hematopoietic diseases (290) 290
imatinib (288) 288
antineoplastic agents (283) 283
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (280) 280
bcr-abl (270) 270
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (267) 267
middle aged (260) 260
adult (259) 259
tyrosine (254) 254
leukemia, myelogenous, chronic, bcr-abl positive - enzymology (253) 253
k562 cells (252) 252
cancer (246) 246
abridged index medicus (233) 233
dasatinib (228) 228
treatment outcome (221) 221
apoptosis (219) 219
fusion proteins, bcr-abl (217) 217
research (207) 207
aged (198) 198
cell biology (198) 198
kinases (198) 198
pharmacology. drug treatments (197) 197
biochemistry & molecular biology (195) 195
drug resistance, neoplasm - genetics (192) 192
genetic aspects (189) 189
cell proliferation - drug effects (186) 186
signal transduction (184) 184
phosphorylation (178) 178
enzyme inhibitors - pharmacology (170) 170
drug resistance, neoplasm - drug effects (167) 167
philadelphia chromosome (162) 162
pyrimidines - administration & dosage (162) 162
proteins (161) 161
protein-tyrosine kinases - metabolism (159) 159
signal transduction - drug effects (157) 157
tumor cells, cultured (157) 157
cml (156) 156
protein-tyrosine kinases - genetics (152) 152
drug resistance (150) 150
bcr protein (149) 149
drug therapy (147) 147
care and treatment (144) 144
fusion protein (144) 144
neoplasms (144) 144
chemotherapy (142) 142
chromosome aberrations (140) 140
pharmacology & pharmacy (138) 138
protein-tyrosine kinase (137) 137
health aspects (136) 136
piperazines - administration & dosage (135) 135
medical genetics (129) 129
tumors (128) 128
dose-response relationship, drug (126) 126
stem cells (126) 126
abl protein (125) 125
protein kinase inhibitors - administration & dosage (123) 123
pyrimidines - adverse effects (122) 122
analysis (121) 121
antineoplastic agents - adverse effects (113) 113
antineoplastic agents - administration & dosage (110) 110
enzyme inhibitors - therapeutic use (110) 110
protein kinase inhibitors - chemistry (108) 108
protein kinase inhibitors - adverse effects (107) 107
clinical trials as topic (105) 105
gene expression (105) 105
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1956) 1956
Japanese (40) 40
French (16) 16
Chinese (15) 15
German (10) 10
Russian (6) 6
Polish (4) 4
Spanish (4) 4
Hungarian (3) 3
Portuguese (3) 3
Czech (2) 2
Italian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2007, Volume 110, Issue 12, pp. 4055 - 4063
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Chemotherapy | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Protein-Tyrosine Kinases - metabolism | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Drug Resistance, Neoplasm | Neoplasm Proteins - antagonists & inhibitors | Piperazines - chemistry | Thiazoles - therapeutic use | Neoplasm Proteins - metabolism | Pyrimidines - chemistry | Dose-Response Relationship, Drug | Protein Kinase Inhibitors - chemistry | Fusion Proteins, bcr-abl | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Protein-Serine-Threonine Kinases - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Dasatinib | Quinone Reductases - metabolism | Piperazines - therapeutic use | Discoidin Domain Receptor 1 | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | Imatinib Mesylate | Piperazines - pharmacology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinone Reductases - antagonists & inhibitors | K562 Cells | Proteomics | Thiazoles - chemistry | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Drug Screening Assays, Antitumor | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer cell, ISSN 1535-6108, 2009, Volume 16, Issue 5, pp. 401 - 412
Journal Article
Leukemia, ISSN 0887-6924, 2019, Volume 33, Issue 7, pp. 1583 - 1597
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Leukemia, Large Granular Lymphocytic - drug therapy | Cell Proliferation | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | STAT5 Transcription Factor - genetics | STAT5 Transcription Factor - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Tumor Suppressor Proteins - genetics | Antineoplastic Agents - pharmacology | Leukemia, Large Granular Lymphocytic - pathology | Tumor Suppressor Proteins - metabolism | Interferons - pharmacology | Survival Rate | Mice, SCID | Cell Transformation, Neoplastic - metabolism | Mice, Knockout | Xenograft Model Antitumor Assays | Fusion Proteins, bcr-abl - genetics | Animals | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Leukemia, Large Granular Lymphocytic - metabolism | Mice, Inbred NOD | Mice | Cell Transformation, Neoplastic - drug effects | Mutation | Cell Transformation, Neoplastic - pathology | Fusion Proteins, bcr-abl - metabolism | RNA sequencing | Usage | Gene mutations | Leukemia | Development and progression | Genetic aspects | Cellular signal transduction | Research | BCR protein | Biotechnology | Transformation | Deregulation | Transcription factors | Profiling | Transcription | Abl gene | BCR gene | Kinases | Gene sequencing | α-Interferon | Signal transduction | Janus kinase | Transducers | Cell survival | Colonies | Inhibition (psychology) | Stat5 protein | Ribonucleic acid--RNA | Disease control | Survival | Hemopoiesis | Lymphocytes B | γ-Interferon | Leukemogenesis | Interferon | Tumors | Index Medicus | Cell signalling | Acute lymphocytic leukaemia
Journal Article
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 04/2017, Volume 31, Issue 10, pp. 2065 - 2074
Journal Article